| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| L | | IP | CI | | Aricept Evess 5 mg | 28 Tablet(s) | 37.09 | 56.25 | 10 % | | Melting tablets: Donepezili Hydrochloridum 5 mg | Pfizer AG | B / SL / SO | FB | G |
| L | | IP | CI | | Aricept Evess 5 mg | 98 Tablet(s) | 129.85 | 155.65 | 10 % | | Melting tablets: Donepezili Hydrochloridum 5 mg | Pfizer AG | B / SL / SO | FB | G |
| L | | IP | CI | | Aricept Evess 10 mg | 28 Tablet(s) | 37.09 | 56.25 | 10 % | | Melting tablets: Donepezili Hydrochloridum 10 mg | Pfizer AG | B / SL / SO | FB | G |
| L | | IP | CI | | Aricept Evess 10 mg | 98 Tablet(s) | 129.85 | 155.65 | 10 % | | Melting tablets: Donepezili Hydrochloridum 10 mg | Pfizer AG | B / SL / SO | FB | G |
| L | | IP | CI | | Aricept 5 mg | 28 Tablet(s) | 37.09 | 56.25 | 10 % | | Coated tablets: Donepezili Hydrochloridum 5 mg | Pfizer AG | B / SL / SO | FB | G |
| L | | IP | CI | | Aricept 5 mg | 98 Tablet(s) | 129.85 | 155.65 | 10 % | | Coated tablets: Donepezili Hydrochloridum 5 mg | Pfizer AG | B / SL / SO | FB | G |
| L | | IP | CI | | Aricept 10 mg | 28 Tablet(s) | 37.09 | 56.25 | 10 % | | Coated tablets: Donepezili Hydrochloridum 10 mg | Pfizer AG | B / SL / SO | FB | G |
| L | | IP | CI | | Aricept 10 mg | 98 Tablet(s) | 129.85 | 155.65 | 10 % | | Coated tablets: Donepezili Hydrochloridum 10 mg | Pfizer AG | B / SL / SO | FB | G |
| L | | IP | CI | | Donepezil NOBEL lingual 5 mg | 28 | 27.99 | 46.90 | 10 % | | | NOBEL Pharma Schweiz AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil NOBEL lingual 5 mg | 98 | 97.39 | 122.35 | 10 % | | | NOBEL Pharma Schweiz AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil NOBEL lingual 10 mg | 28 | 27.99 | 46.90 | 10 % | | Melting tablets: Donepezili Hydrochloridum 10 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil NOBEL lingual 10 mg | 98 | 97.39 | 122.35 | 10 % | | Melting tablets: Donepezili Hydrochloridum 10 mg | NOBEL Pharma Schweiz AG | ● B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil Sandoz 5 mg | 28 Tablet(s) | 27.82 | 46.70 | 10 % | | Coated tablets: Donepezili Hydrochloridum 5 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil Sandoz 5 mg | 98 Tablet(s) | 97.39 | 122.35 | 10 % | | Coated tablets: Donepezili Hydrochloridum 5 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil Sandoz 10 mg | 28 Tablet(s) | 27.82 | 46.70 | 10 % | | Coated tablets: Donepezili Hydrochloridum 10 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil Sandoz 10 mg | 98 Tablet(s) | 97.39 | 122.35 | 10 % | | Coated tablets: Donepezili Hydrochloridum 10 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil Spirig HC 5 mg | 28 Tablet(s) | 28.15 | 47.05 | 10 % | | Coated tablets: Donepezili Hydrochloridum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil Spirig HC 5 mg | 98 Tablet(s) | 97.39 | 122.35 | 10 % | | Coated tablets: Donepezili Hydrochloridum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil Spirig HC 10 mg | 28 Tablet(s) | 28.15 | 47.05 | 10 % | | Coated tablets: Donepezili Hydrochloridum 10 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil Spirig HC 10 mg | 98 Tablet(s) | 97.39 | 122.35 | 10 % | | Coated tablets: Donepezili Hydrochloridum 10 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil-Mepha 5 mg | 30 Tablet(s) | 30.19 | 49.15 | 10 % | | Coated tablets: Donepezili Hydrochloridum 5 mg | Mepha Pharma AG | ● B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil-Mepha 5 mg | 50 Tablet(s) | 50.23 | 71.05 | 10 % | | Coated tablets: Donepezili Hydrochloridum 5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil-Mepha 5 mg | 100 Tablet(s) | 99.38 | 124.40 | 10 % | | Coated tablets: Donepezili Hydrochloridum 5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil-Mepha 10 mg | 30 Tablet(s) | 30.19 | 49.15 | 10 % | | Coated tablets: Donepezili Hydrochloridum 10 mg | Mepha Pharma AG | ● B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil-Mepha 10 mg | 50 Tablet(s) | 50.23 | 71.05 | 10 % | | Coated tablets: Donepezili Hydrochloridum 10 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Donepezil-Mepha 10 mg | 100 Tablet(s) | 99.38 | 124.40 | 10 % | | Coated tablets: Donepezili Hydrochloridum 10 mg | Mepha Pharma AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Donepezil Sandoz 5 mg | 50 Tablet(s) | | | k.A. | | Coated tablets: Donepezili Hydrochloridum 5 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | IP | CI | | Donepezil Sandoz 10 mg | 50 Tablet(s) | | | k.A. | | Coated tablets: Donepezili Hydrochloridum 10 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
|
| L | | IP | CI | | Exelon Patch 5 | 30 plaster(s) | 40.73 | 60.35 | 10 % | | Transdermal patch: Rivastigminum 9 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | | Exelon Patch 10 | 30 plaster(s) | 40.73 | 60.35 | 10 % | | Transdermal patch: Rivastigminum 18 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | | Exelon Patch 10 | 60 plaster(s) | 81.46 | 104.25 | 10 % | | Transdermal patch: Rivastigminum 18 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | | Exelon Patch 15 | 30 plaster(s) | 40.73 | 60.35 | 10 % | | Transdermal patch: Rivastigminum 27 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | | Exelon Patch 15 | 60 plaster(s) | 81.46 | 104.25 | 10 % | | Transdermal patch: Rivastigminum 27 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 5 | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 9 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 10 | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 10 | 60 | 69.24 | 91.70 | 10 % | | Transdermal patch: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 15 | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 27 mg | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 15 | 60 | 69.24 | 91.70 | 10 % | | Transdermal patch: Rivastigminum 27 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch 4.6
mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 6.9 mg | Helvepharm AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch 9.5
mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 13.8 mg | Helvepharm AG | ● B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch 9.5
mg/24 h | 2 x 30 | 69.24 | 91.70 | 10 % | | Transdermal patch: Rivastigminum 13.8 mg | Helvepharm AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch
13.3 mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 19.2 mg | Helvepharm AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch
13.3 mg/24 h | 2 x 30 | 69.24 | 91.70 | 10 % | | Transdermal patch: Rivastigminum 19.2 mg | Helvepharm AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch 4.6
mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermale Pflaster: Rivastigminum 6.4 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch 9.5
mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermale Pflaster: Rivastigminum 12.8 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch 9.5
mg/24 h | 2 x 30 | 69.24 | 91.70 | 10 % | | Transdermale Pflaster: Rivastigminum 12.8 mg | Mepha Pharma AG | ● B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch
13.3 mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermale Pflaster: Rivastigminum 19.2 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch
13.3 mg/24 h | 2 x 30 | 69.24 | 91.70 | 10 % | | Transdermale Pflaster: Rivastigminum 19.2 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Exelon 1,5 mg - T | 28 Capsule(s) | 22.42 | 40.80 | 10 % | | Capsules: Rivastigminum 1.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 1,5 mg - T | 56 Capsule(s) | 40.18 | 60.10 | 10 % | | Capsules: Rivastigminum 1.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 1,5 mg - T | 112 Capsule(s) | 88.12 | 112.25 | 10 % | | Capsules: Rivastigminum 1.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 3 mg - T | 28 Capsule(s) | 22.42 | 40.80 | 10 % | | Capsules: Rivastigminum 3 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 3 mg - T | 56 Capsule(s) | 40.18 | 60.10 | 10 % | | Capsules: Rivastigminum 3 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 3 mg - T | 112 Capsule(s) | 88.12 | 112.25 | 10 % | | Capsules: Rivastigminum 3 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 4,5 mg - T | 28 Capsule(s) | 22.42 | 40.80 | 10 % | | Capsules: Rivastigminum 4.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 4,5 mg - T | 112 Capsule(s) | 88.12 | 112.25 | 10 % | | Capsules: Rivastigminum 4.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 6 mg - T | 28 Capsule(s) | 22.42 | 40.80 | 10 % | | Capsules: Rivastigminum 6 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 6 mg - T | 112 Capsule(s) | 88.12 | 112.25 | 10 % | | Capsules: Rivastigminum 6 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 2 mg/ml | 120 ml | 62.35 | 84.25 | 10 % | | Solution (oral): Rivastigminum 2 mg/ml | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Rivasur due volte alla
settimana 4,6 mg/24 ore | 8 | 32.31 | 51.55 | 10 % | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 25.92 mg | Zambon Svizzera SA | B / SL | FB | G |
| L | | IP | CI | | Rivasur due volte alla
settimana 4,6 mg/24 ore | 16 | 64.62 | 86.70 | 10 % | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 25.92 mg | Zambon Svizzera SA | B / SL | FB | G |
| L | | IP | CI | | Rivasur due volte alla
settimana 9,5 mg/24 ore | 8 | 32.31 | 51.55 | 10 % | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 51.84 mg | Zambon Svizzera SA | B / SL | FB | G |
| L | | IP | CI | | Rivasur due volte alla
settimana 9,5 mg/24 ore | 16 | 64.62 | 86.70 | 10 % | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 51.84 mg | Zambon Svizzera SA | B / SL | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco 4,6
mg/24 h (9mg) | 30 | | | k.A. | | Transdermal patch: Rivastigminum 9 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco 9,5
mg/24 h (18 mg) | 30 | | | k.A. | | Transdermal patch: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco 9,5
mg/24 h (18 mg) | 60 | | | k.A. | | Transdermal patch: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco
13,3 mg/24 h (23,1 mg) | 30 | | | k.A. | | Transdermal patch: Rivastigminum 23.1 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco
13,3 mg/24 h (23,1 mg) | 60 | | | k.A. | | Transdermal patch: Rivastigminum 23.1 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
|
| L | | IP | CI | | Reminyl PR 8 mg | 28 Capsule(s) | 31.01 | 49.85 | 10 % | | Capsules: Galantaminum 8 mg | Essential Pharma
Switzerland GmbH | B / SL / SO | FB | G |
| L | | IP | CI | | Reminyl PR 16 mg | 28 Capsule(s) | 31.01 | 49.85 | 10 % | | Capsules: Galantaminum 16 mg | Essential Pharma
Switzerland GmbH | B / SL / SO | FB | G |
| L | | IP | CI | | Reminyl PR 24 mg | 28 Capsule(s) | 31.01 | 49.85 | 10 % | | Capsules: Galantaminum 24 mg | Essential Pharma
Switzerland GmbH | B / SL / SO | FB | G |
| L | | IP | CI | | Galantamin SR Zentiva 8 mg | 28 | 26.36 | 45.10 | 10 % | | Delayed release capsules: Galantaminum 8 mg | Helvepharm AG | ● B / SL / SG | FB | G |
| L | | IP | CI | | Galantamin SR Zentiva 16 mg | 28 | 26.36 | 45.10 | 10 % | | Delayed release capsules: Galantaminum 16 mg | Helvepharm AG | ● B / SL / SG | FB | G |
| L | | IP | CI | | Galantamin SR Zentiva 24 mg | 28 | 26.36 | 45.10 | 10 % | | Delayed release capsules: Galantaminum 24 mg | Helvepharm AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Galantamin-Mepha retard 8 mg | 7 Capsule(s) | | | k.A. | | Capsules: Galantaminum 8 mg | Mepha Pharma AG | B | FB | G |
| | | IP | CI | | Galantamin-Mepha retard 8 mg | 28 Capsule(s) | | | k.A. | | Capsules: Galantaminum 8 mg | Mepha Pharma AG | B | FB | G |
| | | IP | CI | | Galantamin-Mepha retard 16 mg | 28 Capsule(s) | | | k.A. | | Capsules: Galantaminum 16 mg | Mepha Pharma AG | B | FB | G |
| | | IP | CI | | Galantamin-Mepha retard 16 mg | 84 Capsule(s) | | | k.A. | | Capsules: Galantaminum 16 mg | Mepha Pharma AG | B | FB | G |
| | | IP | CI | | Galantamin-Mepha retard 24 mg | 28 Capsule(s) | | | k.A. | | Capsules: Galantaminum 24 mg | Mepha Pharma AG | B | FB | G |
| | | IP | CI | | Galantamin-Mepha retard 24 mg | 84 Capsule(s) | | | k.A. | | Capsules: Galantaminum 24 mg | Mepha Pharma AG | B | FB | G |
